Pregled bibliografske jedinice broj: 1128412
Systemic therapy of early breast cancer
Systemic therapy of early breast cancer // Libri oncologici : Croatian journal of oncology, 42 (2014), 1-3; 41-50 (recenziran, pregledni rad, stručni)
CROSBI ID: 1128412 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Systemic therapy of early breast cancer
Autori
Šeparović, Robert ; Silovski, Tajana ; Zorica, Robert ; Pavlović, Mirjana ; Vazdar, Ljubica ; Pavlica, Vesna
Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) 42
(2014), 1-3;
41-50
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
breast cancer ; micrometastasis ; adjuvant chemotherapy ; biological therapy ; survival rate
Sažetak
Breast cancer is the most common cancer in women. Early breast cancer is potentially curable disease. Systemic adjuvant therapy is created to treat micrometastatic disease or destroy breast cancer cells that have spread from the breast and regional lymph nodes, but have not yet formed visible distant metastases. Systemic adjuvant therapy is based on chemotherapy with or without targeted therapy, and endocrine therapy, sometimes in combination with adjuvant irradiation, usually is conducted after surgery. The aim of adjuvant therapy is to decrease recurrence rate and extension of overall survival
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore
Profili:
Tajana Silovski
(autor)
Ljubica Vazdar
(autor)
Robert Zorica
(autor)
Robert Šeparović
(autor)
Vesna Pavlica
(autor)
Mirjana Pavlović
(autor)
